IMRIS, Inc. announced that it has obtained Therapeutic Goods Administration (TGA) regulatory listing for VISIUS(R) iCT, the first and only ceiling-mounted intraoperative computed tomography, allowing for sales and marketing in Australia. This is another step in the company overall global launch following US and European approvals. VISIUS iCT offers the high image quality of competing intraoperative systems along with market leading dose management capabilities.

As procedures become less invasive, the need for better visualization with advanced imaging during procedures and low radiation exposure increases. With this unique solution, surgeons can confirm implant placements, fusion and other complex procedure results while still in the OR.